AlphaMark Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $45K | Hold |
500
| – | – | 0.02% | 252 |
|
|
2024
Q3 | $42K | Hold |
500
| – | – | 0.01% | 350 |
|
|
2024
Q2 | $39K | Hold |
500
| – | – | 0.01% | 361 |
|
|
2024
Q1 | $34K | Hold |
500
| – | – | 0.01% | 381 |
|
|
2023
Q4 | $29K | Hold |
500
| – | – | 0.01% | 402 |
|
|
2023
Q3 | $26K | Hold |
500
| – | – | 0.01% | 399 |
|
|
2023
Q2 | $27K | Hold |
500
| – | – | 0.01% | 284 |
|
|
2023
Q1 | $25K | Hold |
500
| – | – | 0.01% | 291 |
|
|
2022
Q4 | $23K | Hold |
500
| – | – | 0.01% | 269 |
|
|
2022
Q3 | $19K | Hold |
500
| – | – | 0.01% | 332 |
|
|
2022
Q2 | $19K | Hold |
500
| – | – | 0.01% | 318 |
|
|
2022
Q1 | $22K | Hold |
500
| – | – | 0.01% | 316 |
|
|
2021
Q4 | $21K | Hold |
500
| – | – | 0.01% | 327 |
|
|
2021
Q3 | $22K | Hold |
500
| – | – | 0.01% | 318 |
|
|
2021
Q2 | $21K | Hold |
500
| – | – | 0.01% | 325 |
|
|
2021
Q1 | $19K | Hold |
500
| – | – | 0.01% | 330 |
|
|
2020
Q4 | $18K | Hold |
500
| – | – | 0.01% | 305 |
|
|
2020
Q3 | $19K | Hold |
500
| – | – | 0.01% | 283 |
|
|
2020
Q2 | $18K | Hold |
500
| – | – | 0.01% | 288 |
|
|
2020
Q1 | $16K | Hold |
500
| – | – | 0.01% | 259 |
|
|
2019
Q4 | $23K | Hold |
500
| – | – | 0.01% | 255 |
|
|
2019
Q3 | $20K | Hold |
500
| – | – | 0.01% | 264 |
|
|
2019
Q2 | $21K | Hold |
500
| – | – | 0.01% | 268 |
|
|
2019
Q1 | $19K | Buy |
500
+150
| +43% | +$5.73K | 0.01% | 267 |
|
|
2018
Q4 | $12K | Hold |
350
| – | – | 0.01% | 295 |
|
|
2018
Q3 | $13K | Hold |
350
| – | – | 0.01% | 322 |
|
|
2018
Q2 | $11K | Hold |
350
| – | – | ﹤0.01% | 349 |
|
|
2018
Q1 | $10K | Buy |
350
+150
| +75% | +$4.08K | ﹤0.01% | 341 |
|
|
2017
Q4 | $5K | Hold |
200
| – | – | ﹤0.01% | 410 |
|
|
2017
Q3 | $6K | Hold |
200
| – | – | ﹤0.01% | 383 |
|
|
2017
Q2 | $6K | Hold |
200
| – | – | ﹤0.01% | 396 |
|
|
2017
Q1 | $5K | Hold |
200
| – | – | ﹤0.01% | 396 |
|
|
2016
Q4 | $4K | Hold |
200
| – | – | ﹤0.01% | 392 |
|
|
2016
Q3 | $5K | Hold |
200
| – | – | ﹤0.01% | 283 |
|
|
2016
Q2 | $5K | Hold |
200
| – | – | ﹤0.01% | 272 |
|
|
2016
Q1 | $4K | Hold |
200
| – | – | ﹤0.01% | 268 |
|
|
2015
Q4 | $4K | Buy |
+200
| New | +$3.58K | ﹤0.01% | 260 |
|
Other funds holding BSX
AlphaMark Advisors's BSX Position: Q4 2024 in Review
AlphaMark Advisors held its Boston Scientific (BSX) position steady in Q4 2024 at 500 shares worth $45K. The position accounts for 0.02% of the portfolio, ranked #252.
AlphaMark Advisors first reported a position in BSX in Q4 2015 and has held it in 37 quarters since. 1,513 funds tracked by Wall St. Rank hold BSX as of Q4 2024.
- AlphaMark Advisors held 500 shares of Boston Scientific worth $45K as of Q4 2024.
- AlphaMark Advisors left its Boston Scientific share count unchanged in Q4 2024.
- Boston Scientific made up 0.02% of AlphaMark Advisors's portfolio in Q4 2024, its #252 holding.
- AlphaMark Advisors first reported a position in Boston Scientific in Q4 2015 and has held it in 37 quarters since.
- 1,513 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2024.
Based on AlphaMark Advisors's 13F filing for Q4 2024, filed 21 Jan 2025.